Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults.
about
Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort studyTreatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settingsAntifungal interventions for the primary prevention of cryptococcal disease in adults with HIVCost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settingsIntegrating cryptococcal antigen screening and pre-emptive treatment into routine HIV careMultisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrastPaucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndromePoint of Care Testing for the Diagnosis of Fungal Infections: Are We There Yet?Preventing Cryptococcosis-Shifting the Paradigm in the Era of Highly Active Antiretroviral TherapyHIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited SettingsIncreased permeability of blood-brain barrier is mediated by serine protease during Cryptococcus meningitisCost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South AfricaA screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward?Low CD4 count plus coma predicts cryptococcal meningitis in TanzaniaCalcineurin governs thermotolerance and virulence of Cryptococcus gattii.A Zebrafish Model of Cryptococcal Infection Reveals Roles for Macrophages, Endothelial Cells, and Neutrophils in the Establishment and Control of Sustained Fungemia.Neuromeningeal cryptococcosis in sub-Saharan Africa: Killer disease with sparse dataDeterminants of disease presentation and outcome during cryptococcosis: the CryptoA/D studyThe temperature-sensitive role of Cryptococcus neoformans ROM2 in cell morphogenesis.Treatment of cryptococcal meningitis in KwaZulu-Natal, South Africa.Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in MalawiCryptococcal meningitis: epidemiology and therapeutic options.Paradoxical roles of alveolar macrophages in the host response to Cryptococcus neoformans.The DEAD-box RNA helicase Vad1 regulates multiple virulence-associated genes in Cryptococcus neoformans.Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohortsPrevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay.Point-of-care lateral flow assays for tuberculosis and cryptococcal antigenuria predict death in HIV infected adults in UgandaScreening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.Symptomatic relapse of HIV-associated cryptococcal meningitis in South Africa: the role of inadequate secondary prophylaxisHow sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans.The prevalence and clinical course of HIV-associated pulmonary cryptococcosis in Uganda.Performance of cryptococcal antigen lateral flow assay using saliva in Ugandans with CD4 <100.Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.Utility of urine and serum lateral flow assays to determine the prevalence and predictors of cryptococcal antigenemia in HIV-positive outpatients beginning antiretroviral therapy in Mwanza, TanzaniaTiming of antiretroviral therapy after diagnosis of cryptococcal meningitis.Cryptococcus neoformans-reactive and total immunoglobulin profiles of human immunodeficiency virus-infected and uninfected UgandansIndependent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patientsResistance to antifungals that target CYP51.Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplantPrevalence and correlates of cryptococcal antigen positivity among AIDS patients--United States, 1986-2012.
P2860
Q21144623-875C0865-8787-4E82-81F5-7D8C8D8FF2E7Q24241096-475120C2-C111-420E-B2BC-CFDBDFCE8D97Q24246431-2621CCA5-E1F9-411F-8DEA-09891E13789CQ24600270-7036B01B-5E4D-43BD-93DE-30CF893CFC51Q24610933-A2FDF8F4-9C3D-48D4-AF44-F7A56AC48026Q24620256-3E136919-DA8A-4A20-B64D-A91E0348B62EQ24630287-8BB3A9F3-DA95-44E8-9853-419A2B4B2B2EQ26746020-3649E9FB-C378-413D-B585-104497165C71Q26994750-B5B1B7C1-44B4-45F8-8022-9B06B0222599Q28078958-C143E436-B58A-414D-BA43-07E86F871D86Q28305427-AACE01F4-5451-4903-95DA-604229BCB9BEQ28534733-892B441E-98D5-4933-9855-A413A516BDDFQ28541690-351796F4-946C-4E41-A70E-70DC87D08AF1Q30444984-DE4D8328-6559-4B98-8E30-FDA89F0E6536Q30536858-D03759D1-5B61-49A0-A9AF-B5262096AC54Q30815458-0A5A46CF-FF80-4837-8394-265C3B403E99Q30934853-CC9FEC39-603D-46E7-BB43-5873D6E75A05Q33272469-B2987075-C757-4C71-BB87-DC1E7B2D8C83Q33281756-D43603E0-CFD8-4F14-9DC2-5FC26202603CQ33523050-E80B0F32-2463-4E14-B4EB-61F7EEFC4417Q33588561-6C4CFC3F-57E3-4925-B0D4-569D0C0F486EQ33633343-DF9E0406-7E45-486A-9BE5-CA46630678C9Q33673568-26D809B4-EACB-4C3A-8A7D-5F53EEA791E3Q33683735-D9EBCA20-8055-487F-9E25-35DDCBA8A792Q33792332-4EF11C4A-397E-4E7F-A872-955A1CB640ABQ33803185-D3B46A93-4C19-4FD9-96C0-A55830E7BD06Q33855961-E244E6F5-6B58-406B-86FF-EF34F18611E9Q33871884-4FD8D153-21D7-470D-A368-B72D8D229F87Q33892987-12CB14C5-098E-4672-B9D8-0CD88B6079FAQ33894565-6087FE89-E888-444F-A1AA-5353623D7606Q33941330-83422EEA-6D25-4F4B-8336-CDDC8AF4DDAEQ33982206-BDC98451-FCCA-4936-8123-A368442C4D78Q34020746-5D68254E-63E3-44BC-AB5E-A3C616401F64Q34024241-B3339E18-8C3C-4A97-87C5-92E4B8605A3CQ34024416-48906DF2-05D2-480F-8192-C1E66AC98B9FQ34072411-34B6B3BF-D040-4178-A338-9152FB60BA05Q34247688-957A9BF0-2ED6-4ED0-8D42-6D2C11A5F554Q34276700-48C51892-FC94-4E7F-84A1-9721FBBAB0A2Q34399223-4B09C6B2-12A1-4A51-97D0-D41780E77CD8Q34428446-30DAD004-C200-4647-880F-37FA9F0CEC1E
P2860
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults.
@en
type
label
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults.
@en
prefLabel
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults.
@en
P2093
P50
P1433
P1476
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults.
@en
P2093
Christine Watera
Eric Lugada
James A G Whitworth
Jessica Nakiyingi
Katherine Gray
Michael Moore
P304
P356
10.1097/00002030-200205030-00009
P407
P577
2002-05-01T00:00:00Z